Cefepime, Piperacillin-Tazobactam, and the Inoculum Effect in Tests with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae

Antimicrobial Agents and Chemotherapy - Tập 45 Số 12 - Trang 3548-3554 - 2001
Kenneth Thomson1, Ellen Smith Moland1
1Center for Research in Antiinfectives and Biotechnology, Department of Medical Microbiology and Immunology, Creighton University School of Medicine, Omaha, Nebraska 68178

Tóm tắt

ABSTRACT There is little information about the clinical effectiveness of cefepime and piperacillin-tazobactam in the treatment of infections caused by extended-spectrum β-lactamase (ESBL)-producing pathogens. Some inferences have been drawn from laboratory studies, which have usually involved only one or a few strains of ESBL-producing Klebsiella pneumoniae or Escherichia coli that produced only a limited range of ESBLs. Such studies are indirect, sometimes conflicting, indicators of efficacy. To extend previous laboratory findings, a study was designed to investigate organism-drug interactions by determining the in vitro activities of eight parenteral β-lactam agents against 82 clinical and laboratory strains of Klebsiella , Escherichia , Enterobacter , Citrobacter , Serratia , Morganella , and Proteus species that produced 22 different ESBLs, alone or in combination with other β-lactamases. Activities were determined in broth microdilution MIC tests using standard and 100-fold-higher inocula. An inoculum effect, defined as an eightfold or greater MIC increase on testing with the higher inoculum, was most consistently detected with cefepime, cefotaxime, and ceftriaxone and least frequently detected with meropenem and cefoteten. Piperacillin-tazobactam was intermediate between these two groups of agents. Although the inoculum effect is an in vitro laboratory phenomenon, if it has any predictive value in identifying increased risk of therapeutic failure in serious infections, these results support suggestions that cefepime may be a less-than-reliable agent for therapy of infections caused by ESBL-producing strains.

Từ khóa


Tài liệu tham khảo

10.1007/BF01647010

10.1007/BF01968060

10.1128/AAC.38.4.761

10.1128/AAC.39.2.308

10.1016/S0140-6736(87)90891-9

10.1128/AAC.39.6.1211

10.1128/AAC.33.11.1915

10.1128/AAC.44.11.3177-3179.2000

10.1093/jac/35.1.7

10.1128/jcm.34.2.358-363.1996

10.1128/AAC.34.5.858

10.1128/AAC.35.9.1697

10.1093/clinids/10.4.867

10.1128/AAC.39.5.1187

10.1093/jac/37.1.203

Korzeniowski O. Kaye D. Endocarditis Infectious diseases 2nd ed. Gorbach S. L. Bartlett J. G. Blacklow N. R. 1998 663 674 W. B. Saunders Company Philadelphia Pa

10.1128/AAC.38.2.195

10.1093/jac/41.suppl_4.25

10.1128/AAC.43.7.1669

10.1099/00221287-88-1-169

10.1128/AAC.36.9.1883

National Committee for Clinical Laboratory Standards Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4. 1997 National Committee for Clinical Laboratory Standards Villanova Pa

National Committee for Clinical Laboratory Standards Performance standards for antimicrobial susceptibility testing; tenth informational supplement (aerobic dilution) M100-S10. 2000 NCCLS Wayne Pa

10.1128/AAC.37.3.566

O'Callaghan C. H. Muggleton P. W. Ross G. W. Effects of beta-lactamase from gram-negative organisms on cephalosporins and penicillins. Antimicrob. Agents Chemother. 8 1968 57 63

10.1046/j.1469-0691.2000.00107.x

10.1128/JCM.39.6.2206-2212.2001

10.1086/517217

10.1093/jac/16.1.1

10.1007/BF01650727

10.1046/j.1469-0691.2000.00002.x

10.1128/AAC.38.11.2663

10.1093/clinids/23.1.118

10.1128/AAC.34.11.2193

10.1128/AAC.30.3.403

Sambrook J. Fritsch E. F. Maniatis T. Molecular cloning: a laboratory manual 2nd ed. 1989 Cold Spring Harbor Laboratory Press Cold Spring Harbor N.Y

Sanders C. C. Cefepime: the next generation? Clin. Infect. Dis. 17 1993 369 379

Sanders C. C. In vitro activity of fourth generation cephalosporins against enterobacteriaceae producing extended-spectrum beta-lactamases. J. Chemother. 8 (Suppl. 2) 1996 57 62

10.1128/AAC.30.6.951

10.1093/jac/36.suppl_A.19

Stratton C. W. In vitro testing: correlations between bacterial susceptibility body fluid levels and effectiveness of antibacterial therapy Antibiotics in laboratory medicine 3rd ed. Lorian V. 1991 849 879 Williams & Wilkins Baltimore Md

10.1093/jac/2.2.115

10.1128/AAC.41.5.1053

Thomson K. S. Prevan A. M. Sanders C. C. Novel plasmid-mediated β-lactamases in Enterobacteriaceae: emerging problems for new β-lactam antibiotics Current clinical topics in infectious diseases Remington J. S. Swartz M. N. 16 1996 151 163 Blackwell Science, Inc. Cambridge, Mass

10.1016/S1286-4579(00)01276-4

10.1007/BF01713572

10.1093/clinids/21.4.915

Thông tin
Thông tin xuất bản

Antimicrobial Agents and Chemotherapy

Tập 45 Số 12

3548-3554

Thông tin tác giả